MEIP MEI PHARMA INC Disposals and divestitures 8-K Filing 2024 - Asset Sale MEI Pharma sold its rights and assets related to ME-344 to Aardvark Therapeutics for an initial payment of $500,000 and potential milestone payments up to $62 million based on future achievements.Get access to all SEC 8-K filings of the MEI PHARMA INC